Treating hypertension – a new approach
Hypertension is the leading cause of cardiovascular disease, affecting 1.13 billion people worldwide, including six million adult Australians.
Research has indicated that a new pharmacological...
PSA’s projects make a bigger impact than ever before
The PSA released its 2025 Strategic Projects Impact Report last week, showcasing its leadership in advancing pharmacist practice.
Harnessing different abilities
Some might assume employing someone with a declared disability would only bring complications. But some community pharmacies around Australia are leading the way in...
Taking an idea to reality
The winner of the first PSA Shark Tank is no minnow. SetDose has a $42 billion problem in its sights: medication and dosing errors.
To...
Vale FIP President Dominique Jordan
Tributes have been paid to International Pharmaceutical Federation President Mr Dominique Jordan, who sadly passed away on 19 August.
Hotline data reveals Australians’ pharmacy questions
What are the health questions Australian most want answers to? Data from Medicines Line, the NPS MedicineWise pharmacist-staffed information hotline, has revealed common medical...













